Related Experiment Videos
Interleukin-1 alpha mediates phorbol ester-induced inflammation and epidermal hyperplasia
W Y Lee1, M F Lockniskar, S M Fischer
1Division of Pharmacology/Toxicology, College of Pharmacy, University of Texas at Austin 78712.
Summary
Interleukin-1 alpha (IL-1 alpha) drives skin inflammation and hyperplasia caused by the tumor promoter 12-O-tetradecanoylphorbol-13-acetate (TPA). Blocking IL-1 alpha with antibodies reduces these TPA-induced skin responses.
Area of Science:
- Dermatology
- Immunology
- Carcinogenesis
Background:
- 12-O-tetradecanoylphorbol-13-acetate (TPA) is a tumor promoter inducing skin inflammation and hyperplasia.
- TPA elevates interleukin-1 alpha (IL-1 alpha) in mouse epidermis, a key inflammatory cytokine.
Purpose of the Study:
- To investigate the role of IL-1 alpha in TPA-induced skin responses.
- To determine if IL-1 alpha mediates inflammation and hyperplasia in TPA-treated skin.
Main Methods:
- Topical TPA application to murine skin to assess IL-1 alpha production.
- Intradermal injection of IL-1 alpha and anti-IL-1 alpha antibodies to measure vascular permeability, inflammatory cell infiltration, and epidermal hyperplasia.
- Evans blue dye leakage assay for vascular permeability.
Main Results:
- TPA enhanced IL-1 alpha protein in suprabasal keratinocytes.
- Injected IL-1 alpha increased vascular permeability, inflammatory cell infiltration, and epidermal hyperplasia.
- Anti-IL-1 alpha antibodies blocked TPA-induced vascular permeability, inflammation, and hyperplasia.
Conclusions:
- IL-1 alpha directly or indirectly mediates TPA-induced inflammatory and hyperplastic skin responses.
- IL-1 alpha plays a significant role in the promotion stage of skin carcinogenesis.